A V Therapeutics, inc.
Major shift in treating Prostate Cancer, 100% focused on disease vs. the 10% or less of hormone based treatments + new Therapeutic Vac.
- Stage Full Product Ready
- Industry Biotechnology
- Location New York City, NY, USA
- Currency USD
- Founded April 2007
- Employees 8
- Website avtherapeutics.com
Company Summary
A mature/newest science technology representing a major paradigm shift in the treatment of Prostate Cancer with a low toxicity Capridine chemo drug (capable of being mixed with 200 other approved agents to lower the overall treatment toxicity) & a new Therapeutic Vaccine, four patents, world class Clinicians & Science team . For all the right reasons, we have purposely maintained a stealthy presence until now. Our new Medical Advisory Bd.
Team
-
Abe Mittleman, MDCEO
See slides
-
Morton Coleman, MDSr.VP &Director
See slidee & please google him
Head of the Lymphoma, etc diseases at NYP Weill Cornell Hospital & Medical School -
Howard Scher, MDDirector
@ SKMCC and head of the 13 university Prosatate Consortium
-
Raj TiawariCSO
See slide & originator of our 4 patents
Advisors
-
Merrill Kraines, Fulbright.comLawyerUnconfirmedMorton Gelb, Morton A Gelb, CPA,LLCAccountantUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.